-
2
-
-
0033775218
-
Osteoarthritis: New insight. Part 1: the disease and its risk factor
-
Felson D. T., Lawrence R. C. et al. Osteoarthritis: new insight. Part 1: The disease and its risk factor. Ann. Intern. Med. 2000; 133: 635-646.
-
(2000)
Ann. Intern. Med.
, vol.133
, pp. 635-646
-
-
Felson, D.T.1
Lawrence, R.C.2
-
4
-
-
0033712395
-
The role of the chondrocyte in osteoarthritis
-
Golding M. B. The role of the chondrocyte in osteoarthritis. Acthr. and Rheum. 2000; 43: 1916-1926.
-
(2000)
Acthr. and Rheum.
, vol.43
, pp. 1916-1926
-
-
Golding, M.B.1
-
6
-
-
0034619417
-
Osteoarthritis: New insight. Part 2: Treatment approach
-
Felson D. T., Lawerence R. C. et al: Osteoarthritis: new insight. Part 2: Treatment approach. Ann. Intern. Med. 2000; 133: 726-737.
-
(2000)
Ann. Intern. Med.
, vol.133
, pp. 726-737
-
-
Felson, D.T.1
Lawerence, R.C.2
-
7
-
-
0028040638
-
Guidelines for testing slow acting drugs in Osteoarthritis
-
Leguesne M., Brandt K., Bellamy N. et al. Guidelines for testing slow acting drugs in Osteoarthritis. J. Rheumatol. 1994; 21 (suppl. 21): 65-73.
-
(1994)
J. Rheumatol.
, vol.21
, Issue.21 SUPPL.
, pp. 65-73
-
-
Leguesne, M.1
Brandt, K.2
Bellamy, N.3
-
8
-
-
24044492544
-
-
Russian source
-
-
-
-
9
-
-
0026507880
-
Proteoglycans: Many forms, many functions
-
Hardigham T. E., Fosang A. J. Proteoglycans: many forms, many functions. FASEB J. 1992; 6: 681-870.
-
(1992)
FASEB J.
, vol.6
, pp. 681-870
-
-
Hardigham, T.E.1
Fosang, A.J.2
-
10
-
-
0031833414
-
The role of nitric oxide in articular cartilage breakdown in oateoarthritis
-
Amin A. R., Abramson S. B. The role of nitric oxide in articular cartilage breakdown in oateoarthritis. Cur. Opin. Rheumatol. 1998; 10: 263-268.
-
(1998)
Cur. Opin. Rheumatol.
, vol.10
, pp. 263-268
-
-
Amin, A.R.1
Abramson, S.B.2
-
11
-
-
0025274259
-
Metabolic fate of exogenous chondroitin sulfate in the experimental animal
-
Palmieri L., Conte A., Giovannini L. et al. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneim-Fosch/Drug. Res. 1990; 40: 319-323.
-
(1990)
Arzneim-Fosch/Drug. Res.
, vol.40
, pp. 319-323
-
-
Palmieri, L.1
Conte, A.2
Giovannini, L.3
-
13
-
-
0029160101
-
Biochemical and pharmacological aspects of oral treatment with chondroitin sulfate
-
Conte A., Volpi N., Palmieri L. et al. Biochemical and pharmacological aspects of oral treatment with chondroitin sulfate. Arzneim-Fosch/Drug. Res. Ibid. 1995; 45: 918-925.
-
(1995)
Arzneim-Fosch/Drug. Res.
, vol.45
, pp. 918-925
-
-
Conte, A.1
Volpi, N.2
Palmieri, L.3
-
14
-
-
0021282151
-
Interaction between human leukocyte elasrase and chondroitin sulfate
-
Baici A., Bradamante P. Interaction between human leukocyte elasrase and chondroitin sulfate. Chem. Biol. Interact. 1984; 51: 1-11.
-
(1984)
Chem. Biol. Interact.
, vol.51
, pp. 1-11
-
-
Baici, A.1
Bradamante, P.2
-
15
-
-
24044444242
-
In vivo chondroprotection of glucosamine and chondroitin sulfate in a rabit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro
-
Lippielo L., Grande D. In vivo chondroprotection of glucosamine and chondroitin sulfate in a rabit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Ann Rheum. Dis. 2000; 59 (suppl. 1): 266.
-
(2000)
Ann Rheum. Dis.
, vol.59
, Issue.1 SUPPL.
, pp. 266
-
-
Lippielo, L.1
Grande, D.2
|